ANTI-HHMIgG ANTIBODY HAVING FUNCTION AS NEW TUMOR MARKER FOR HEPATOCELLULAR CARCIMONA, SCREENING METHOD OF HEPATOMA, AND UTILIZATION AS MARKER OF DEGREE OF PROGRESSION OF HEPATOMA

摘要

PROBLEM TO BE SOLVED: To screen hepatoma, and to utilize as a marker of the degree of progression, by measuring the concentration of anti-HHMIgG in serum by paying attention to a positive ratio of an anti-HHMIgG antibody in serum of a hepatoma patient.;SOLUTION: This invention is attained by paying attention to the fact that, when examining the positive ratio of the anti-HHMIgG antibody between a liver cirrhosis C combined hepatocellular carcimona patient group and a liver cirrhosis C patient group, the positive ratio of the anti-HHMIgG antibody in the serum in the liver cirrhosis C combined hepatocellular carcimona patient group shows such a high value that six samples out of nine samples are positive, and the positive ratio thereof in the liver cirrhosis C patient group shows such a low value that only one sample out of three samples is positive.;COPYRIGHT: (C)2006,JPO&NCIPI